On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health policy acts.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manuf

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday.